These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10603586)

  • 1. [Intravenous immunoglobulins commercialized in Spain and potential risk of acute renal failure].
    Escoms Moreno MC; Riera Molist N; Montoro Ronsano JB
    Med Clin (Barc); 1999 Sep; 113(8):318. PubMed ID: 10603586
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity of intravenous immunoglobulin in the setting of liver transplantation or HBV-related cirrhosis: an undervalued topic.
    Angeli P; Scaglione F
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):259-75. PubMed ID: 18614975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
    Ankersmit HJ; Hacker S; Hoetzenecker K; Moser B; Wolner E
    J Heart Lung Transplant; 2006 Nov; 25(11):1387-8. PubMed ID: 17097508
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute renal failure induced by intravenous immune globulin.
    Arunabh ; Arunabh S; Kumar G; Avila V
    Am Fam Physician; 1996 Feb; 53(3):862, 865. PubMed ID: 8594861
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Known and potential risks related to the use of high dose intravenous immunoglobulins].
    Bussel A
    Ann Dermatol Venereol; 1997; 124(5):381-3. PubMed ID: 9739894
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal toxicity of intravenous immunoglobulin.
    Kobosko J; Nicol P
    Clin Nephrol; 1992 Apr; 37(4):216-7. PubMed ID: 1582063
    [No Abstract]   [Full Text] [Related]  

  • 11. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.
    Parker C
    CMAJ; 2000 Oct; 163(7):881, 885. PubMed ID: 11033724
    [No Abstract]   [Full Text] [Related]  

  • 13. Important drug warning: Immune Globulin Intravenous (human) (IGIV) products.
    Epstein JS; Zoon KC
    Neonatal Netw; 2000 Mar; 19(2):60-2. PubMed ID: 11949001
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
    Jankowski A
    Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the incidence of acute phosphate nephropathy.
    Markowitz GS; Radhakrishnan J; D'Agati VD
    J Am Soc Nephrol; 2007 Dec; 18(12):3020-2. PubMed ID: 18003786
    [No Abstract]   [Full Text] [Related]  

  • 20. A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin.
    Gordon DJ; Sloan SR; de Jong JL
    Am J Hematol; 2009 Nov; 84(11):771-2. PubMed ID: 19806664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.